Envision Pharma
Medical affairs, market access and commercialization services plus AI platforms for pharma and biotech companies
Highlights
- New on EvolcAdded 2026-10-31
About Envision Pharma
Envision Pharma Group is a technology-enabled solutions partner for life sciences organisations. It combines medical, commercial and strategic expertise with its AI-powered platforms, EnvisionOne and iEnvision, across the product lifecycle, from evidence and medical affairs to commercialization, market access, revenue management and compliance.
Its clients are pharmaceutical, biotechnology and medical technology companies, including all top 20 pharma companies according to the website, which states more than 400 clients. Work is organised into strategic service solutions, technology solutions and managed services. Business units include Two Labs (commercialization, including Shepherds Safety Services), Riparian (pricing, access and value optimisation) and four medical communications agencies: Envision 90TEN, Envision Spark, Envision Ignite and Envision Catalyst.
The company is registered in the United Kingdom and headquartered in Horsham. The website dates its origins to 2001, when it began as a medical publications planning business, and the registry records the company as founded in 2002. It states it has 14 offices across four continents and an office in Tokyo, and describes more than 20 years of work for life sciences clients.
Product: Strategic consulting, medical communications, commercialization, market access and managed services, supported by the EnvisionOne and iEnvision AI platforms.
Jobs at Envision Pharma
Leadership
- Tom Langan · Chief Executive OfficerSource: company website
- Adam Deutsch · Chief Operations and Legal OfficerSource: company website
- Ben Rudnick · Chief Financial OfficerSource: company website
- Darren Coleman · EVP, Chief Information OfficerSource: company website
- Florina Krawchick · Chief People OfficerSource: company website
- Jay Ferro · President, Technology and Chief Product OfficerSource: company website
- Ray Joske · Chief Commercial OfficerSource: company website
More biotech & pharma companies
Epidarex Exeed
Seeds early-stage life science ventures by developing breakthrough therapeutic research into investable assetsNew on EvolcEpitopea
Develops off-the-shelf RNA cancer immunotherapies for patients with difficult-to-treat cancersNew on EvolcEpsilogen
Develops antibody-based cancer treatments, including a clinical candidate for ovarian cancerNew on EvolcEvestia Clinical
Clinical research organisation providing trial management, monitoring and regulatory services to biotech sponsorsNew on EvolcExciting Instruments
Benchtop single-molecule fluorescence instruments for academic and biopharma labs studying molecular dynamicsNew on EvolcExtracellular
CDMO for cell-based food, cosmetics and materials products, offering bioprocess development and up to 2,000L manufacturingYoung companyNew on EvolcSalary transparent
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Elementor
- Google Analytics 4
- Google Tag Manager
- OneTrust
- WordPress
- jQuery